Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | SRRK | ADMA | ||
| Company | Apellis Pharmaceuticals Inc | Scholar Rock Holding Corp | Adma Biologics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 33.16 | 41.76 | 17.16 | ||
| High | 34.27 | 45.84 | 17.96 | ||
| Low | 32.89 | 41.53 | 17.08 | ||
| Last | 33.21 | 44.78 | 17.40 | ||
| Change | +0.07 | +2.69 | -0.50 | ||
| % Change | +0.21% | +6.39% | -2.79% | ||
| Volume | 3,733,200 | 2,884,100 | 6,941,500 | ||
| 20-Day Average Volume | 3,212,990 | 1,345,110 | 2,772,595 | ||
| Previous Close | 33.14 | 42.09 | 17.90 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.63 | 40.79 | 19.54 | ||
| 20-Day Raw Stochastic | 68.66% | 92.90% | 6.26% | ||
| 20-Day Relative Strength | 54.11% | 67.33% | 41.45% | ||
| Weighted Alpha | -40.95 | -9.43 | +175.06 | ||
| Today's Opinion | 24% Sell | 100% Buy | 40% Buy | ||
| Previous Opinion | 24% Sell | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 12/13/24 | +6.67% since 12/13/24 | -6.40% since 12/13/24 | ||
| Low | 32.71 on 12/16/24 | 40.22 on 12/19/24 | 17.08 on 12/20/24 | ||
| High | 35.71 on 12/18/24 | 45.84 on 12/20/24 | 19.19 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +20.81% since 11/20/24 | +60.73% since 11/20/24 | -18.58% since 11/20/24 | ||
| Low | 26.62 on 11/21/24 | 25.88 on 11/21/24 | 17.08 on 12/20/24 | ||
| High | 35.72 on 12/09/24 | 46.19 on 12/10/24 | 22.19 on 11/27/24 | ||
| 3-Month | |||||
| %Chg | +2.15% since 09/20/24 | +376.89% since 09/20/24 | -12.91% since 09/20/24 | ||
| Low | 24.34 on 11/05/24 | 6.76 on 10/03/24 | 15.33 on 10/21/24 | ||
| High | 35.72 on 12/09/24 | 46.19 on 12/10/24 | 23.64 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | -16.41% since 06/20/24 | +439.52% since 06/20/24 | +62.46% since 06/20/24 | ||
| Low | 24.34 on 11/05/24 | 6.76 on 10/03/24 | 10.21 on 08/05/24 | ||
| High | 42.47 on 07/16/24 | 46.19 on 12/10/24 | 23.64 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,131,091 | 4,192,079 | 4,113,186 | ||
| Shares Outstanding, K | 124,393 | 93,615 | 236,390 | ||
| Annual Sales | 396,590,000 | 0 | 258,220,000 | ||
| Annual Net Income | -528,630,000 | -165,790,000 | -28,240,000 | ||
| Last Quarter Sales | 196,830,000 | 0 | 119,840,000 | ||
| Last Quarter Net Income | -57,450,000 | -64,480,000 | 35,910,000 | ||
| 60-Month Beta | 0.94 | 0.58 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.46 on 11/05/24 | -0.66 on 11/12/24 | 0.15 on 11/07/24 | ||
| Latest Earnings Date | 11/05/24 | 11/12/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 44.75 | ||